DE60234642D1 - Verhinderung von hautlappennekrose in der plastischen chirurgie - Google Patents
Verhinderung von hautlappennekrose in der plastischen chirurgieInfo
- Publication number
- DE60234642D1 DE60234642D1 DE60234642T DE60234642T DE60234642D1 DE 60234642 D1 DE60234642 D1 DE 60234642D1 DE 60234642 T DE60234642 T DE 60234642T DE 60234642 T DE60234642 T DE 60234642T DE 60234642 D1 DE60234642 D1 DE 60234642D1
- Authority
- DE
- Germany
- Prior art keywords
- necrosis
- lapse
- prevention
- skin
- plastic surgery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000017074 necrotic cell death Effects 0.000 title abstract 2
- 238000002316 cosmetic surgery Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000036770 blood supply Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002840 nitric oxide donor Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- ICRHORQIUXBEPA-UHFFFAOYSA-N thionitrous acid Chemical compound SN=O ICRHORQIUXBEPA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33617501P | 2001-12-06 | 2001-12-06 | |
| PCT/US2002/036138 WO2003049593A2 (en) | 2001-12-06 | 2002-12-02 | Prevention of flap necrosis in plastic surgery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60234642D1 true DE60234642D1 (de) | 2010-01-14 |
Family
ID=23314894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60234642T Expired - Lifetime DE60234642D1 (de) | 2001-12-06 | 2002-12-02 | Verhinderung von hautlappennekrose in der plastischen chirurgie |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060153931A1 (enExample) |
| EP (1) | EP1463440B1 (enExample) |
| JP (2) | JP4563679B2 (enExample) |
| AT (1) | ATE450187T1 (enExample) |
| AU (1) | AU2002365036B2 (enExample) |
| CA (1) | CA2467245A1 (enExample) |
| DE (1) | DE60234642D1 (enExample) |
| WO (1) | WO2003049593A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
| JP2007532697A (ja) | 2004-04-19 | 2007-11-15 | ストラテジック サイエンス アンド テクノロジーズ， エルエルシー | 局所的血流増大の有益な効果 |
| US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
| CN102481275B (zh) | 2009-06-24 | 2014-07-23 | 战略科学技术有限公司 | 含有布洛芬的表面组合物 |
| US12138268B2 (en) | 2009-06-24 | 2024-11-12 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
| EP2445493A1 (en) | 2009-06-24 | 2012-05-02 | Strategic Science & Technologies, LLC | Topical composition containing naproxen |
| CN103442723A (zh) | 2010-12-29 | 2013-12-11 | 战略科学与技术有限责任公司 | 治疗变态反应和其它适应症的系统和方法 |
| EP2658551B1 (en) | 2010-12-29 | 2020-07-01 | Strategic Science & Technologies, LLC | Treatment of erectile dysfunction and other indications |
| WO2020185674A1 (en) * | 2019-03-08 | 2020-09-17 | South Dakota Board Of Regents | A vasoactive topical compound to affect tissue blood flow, reduce tissue necrosis and promote healing |
| CN112843241B (zh) * | 2021-01-14 | 2023-07-25 | 中国药科大学 | 可生物响应的一氧化氮供体型聚合物前药及其制备方法 |
| EP4536264A4 (en) * | 2022-06-08 | 2026-08-05 | Univ Virginia Commonwealth | Guest/host inclusion complexes containing S-nitrosoglutathione and their methods of use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300302A (en) * | 1990-10-04 | 1994-04-05 | Nestec S.A. | Pharmaceutical composition in gel form in a dispensing package |
| JP2599031B2 (ja) * | 1990-11-30 | 1997-04-09 | 宇部興産株式会社 | 高純度亜硝酸アルキルエステルの製造法 |
| PT719145E (pt) * | 1994-05-27 | 2001-01-31 | Cellegy Pharma Inc | Composicao dadora de oxido nitrico para tratamento de desordens anais |
| US5770645A (en) * | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
| US6232434B1 (en) * | 1996-08-02 | 2001-05-15 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
| US5797887A (en) * | 1996-08-27 | 1998-08-25 | Novovasc Llc | Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation |
| WO1998050430A2 (en) * | 1997-05-02 | 1998-11-12 | Somatogen, Inc. | Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| US6395736B1 (en) * | 1998-12-14 | 2002-05-28 | Cellegy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
| AU3490300A (en) * | 1999-03-12 | 2000-10-04 | Nitromed, Inc. | Dopamine agonists in combination with nitric oxide donors, compositions and methods of use |
| US6359182B1 (en) * | 2000-10-26 | 2002-03-19 | Duke University | C-nitroso compounds and use thereof |
-
2002
- 2002-12-02 JP JP2003550646A patent/JP4563679B2/ja not_active Expired - Fee Related
- 2002-12-02 CA CA002467245A patent/CA2467245A1/en not_active Abandoned
- 2002-12-02 DE DE60234642T patent/DE60234642D1/de not_active Expired - Lifetime
- 2002-12-02 AT AT02804687T patent/ATE450187T1/de not_active IP Right Cessation
- 2002-12-02 WO PCT/US2002/036138 patent/WO2003049593A2/en not_active Ceased
- 2002-12-02 EP EP02804687A patent/EP1463440B1/en not_active Expired - Lifetime
- 2002-12-02 AU AU2002365036A patent/AU2002365036B2/en not_active Ceased
- 2002-12-02 US US10/521,394 patent/US20060153931A1/en not_active Abandoned
-
2009
- 2009-12-03 JP JP2009275959A patent/JP5266191B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20060153931A1 (en) | 2006-07-13 |
| JP2010047619A (ja) | 2010-03-04 |
| WO2003049593A3 (en) | 2004-02-19 |
| JP5266191B2 (ja) | 2013-08-21 |
| EP1463440A2 (en) | 2004-10-06 |
| AU2002365036A1 (en) | 2003-06-23 |
| WO2003049593A2 (en) | 2003-06-19 |
| AU2002365036B2 (en) | 2006-09-21 |
| ATE450187T1 (de) | 2009-12-15 |
| JP2005511708A (ja) | 2005-04-28 |
| EP1463440B1 (en) | 2009-12-02 |
| CA2467245A1 (en) | 2003-06-19 |
| EP1463440A4 (en) | 2008-01-23 |
| JP4563679B2 (ja) | 2010-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1116463T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| EP1463440A4 (en) | PREVENTION OF NECROSIS OF PLASTIC SURGERY RASTERS | |
| BRPI0407897A (pt) | derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios | |
| MX2010004549A (es) | Composiciones y métodos bacteriostáticos o bactericidas. | |
| ECSP099427A (es) | Barra de Tierra Segunda Generación 16 conexiones | |
| EA200501095A1 (ru) | Фенилацетамиды и их применение в качестве модуляторов глюкокиназы | |
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| EA200200431A1 (ru) | Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства | |
| ATE408601T1 (de) | Fredericamycin-derivate | |
| CY1113286T1 (el) | Συνθεση με στροντιο και βιταμινη d για την προφυλαξη ή/καιθεραπευτικη αντιμετωπιση των παθησεων των χονδρων ή/και των οστων | |
| ATE505488T1 (de) | Modulator von coagulationskaskaden und fibrinolytischen kaskaden | |
| ATE552031T1 (de) | Pharmazeutische zusammensetzungen enthaltend nicht-acyliertes ghrelin zur behandlung von insulinresistenz | |
| WO2006048829A3 (en) | Preparation of chitin and derivatives thereof for cosmetic and therapeutic use | |
| CY1109513T1 (el) | Φαρμακευτικη συνθεση μικροσφαιριδιων για την προληψη του ακρωτηριασμου διαβητικου ποδιου | |
| ES2250416T3 (es) | Estimulante de secreciohn de hormona de crecimiento. | |
| BRPI0515582A (pt) | 3-(2-hidroxifenil)pirazóis e seu uso como moduladores de hsp90 | |
| EA200601777A1 (ru) | Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии | |
| AR025449A1 (es) | Soluciones farmaceuticas de levosimendan | |
| DE60123665D1 (de) | Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel | |
| SE0102147D0 (sv) | New methods | |
| ES2173124T3 (es) | Composicion de dermatano sulfato utilizado como antitrombotico. | |
| AR063603A1 (es) | Usos de variantes de un activador de plasminogeno de tejidos | |
| EA200500941A1 (ru) | Средство для лечения болезней суставов | |
| CY1124904T1 (el) | Τυροθρικινη για χρηση στην αγωγη ή προληψη σωματικων οσμων καθως και παρασκευασματα γι'αυτην | |
| ATE454139T1 (de) | Arzneimittel mit shikonin als wirkstoff |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |